What are the most common causes of delays in the approval process when applying for a Hong Kong pharmaceutical licence?

In our years of practice, we have observed several recurring causes of approval delays. The most common is inadequate preparation of application documents, including incorrect information, missing documents and failure to follow the required format. This directly triggers requests for further information and can cost several weeks. Second, the leased premises may have compliance issues, such as inadequate fire safety, a lack of an independent temperature-control system or insufficient security. This can prevent the site inspection from being passed at the first attempt and require substantial time for remediation and reinspection. Third, the appointed Responsible Person (RP) may lack the necessary qualifications or have an unclear understanding of the regulations, and perform poorly in an interview with inspectors, raising concerns about their ability to fulfil the role. External factors, such as a backlog of individual applications at government departments or public holidays, may also affect the overall approval time to some extent. Avoiding these controllable internal causes of delay is key to expediting approval.